1. Home
  2. |Insights
  3. |Dealmakers Breakfast Series: How Dealmaking in the Health Care Industry is Evolving

Dealmakers Breakfast Series: How Dealmaking in the Health Care Industry is Evolving

Event | 09.27.18, 4:30 AM EDT - 6:00 AM EDT

Address

Grant Thornton LLP
757 Third Avenue, 9th Floor, New York, NY

Crowell & Moring LLP and Grant Thornton LLP invite you to join us for a breakfast panel discussion on how dealmaking in the health care industry is evolving.


Despite regulatory and policy uncertainty and the emergence of highly disruptive business models, M&A activity continues its record-setting pace, and valuation multiples continue to climb across all sectors of health care. During this program, we will discuss the most significant issues affecting the health care industry, how buyers are evaluating and finding value, and what’s on the horizon for dealmakers investing in this space.


Hosts:

Moderator:

  • Lance Beder, Partner, Transaction Services Health Care Leader, Grant Thornton 

Panelists:

  • Mark Cabrera, Managing Director, Co-Head of Health Care, Oppenheimer & Co. 
  • Robin Shah, Former Flatiron Health Executive 
  • Bill Case, Partner, Clearview Capital 
  • Jodi Daniel, Partner, Health Care Group, Crowell & Moring
Dealmakers Breakfast Series
The Dealmakers Breakfast Series programs are invitation only and focused on senior-level professionals from private equity funds, family office groups, and other institutional investors.

For more information, please contact:

Mae Hsieh, Crowell & Moring LLP
mhsieh@crowell.com | 212.895.4241

Miriam Oh, Grant Thornton LLP
miriam.oh@us.gt.com | 917.742.8662

For more information, please visit these areas: Corporate and Transactional

Insights

Event | 02.20.25

Has the Buss Stopped? Recoupment Today

Has the Buss Stopped? Recoupment Today: In 1997, the California Supreme Court decided Buss v. Superior Court. In Buss, the court concluded that a liability insurer that defended a mixed action could seek reimbursement from the insured for the defense costs associated with the claims that were not even potentially covered. Since then, numerous courts have held that insurers are entitled to recoup their defense costs associated with uncovered claims or causes of action. On the other hand, a significant number of courts have rejected insurers’ right to recoupment, at least in the absence of a policy provision granting the insurer that right. Some commentators have even suggested that the current judicial trend might be away from permitting insurers to recoup their defense costs. Is that correct? Has the Buss stopped? This panel of coverage experts will analyze insurers’ claimed right to recoupment today, and offer their perspectives on what the law on recoupment should perhaps be and might be in the future.